Results 131 to 140 of about 46,553 (219)

Practical Approach to Managing SCIg Treatment in Patients With Chronic Inflammatory Demyelinating Polyneuropathy. [PDF]

Muscle Nerve
Vu T, Guerra C, Suresh N, Khella S, Morrell J, Pulley M, Jiang N, Sharma K, Bertorini T, Jerath N, Peltier A.   +10 more
europepmc   +1 more source

Clinical features of chronic inflammatory demyelinating polyneuropathy: a single-center experience with 33 patients. [PDF]

Front Neurol
Nomura T, Misumi Y, Ueda M.
europepmc   +1 more source

Association between Proteinuria and Risk of Chronic Inflammatory Demyelinating Polyneuropathy/Multifocal Motor Neuropathy: A Nationwide Population-based Cohort Study. [PDF]

J Epidemiol Glob Health
Kwon S, Park YB, Han KD, Jang HR, Choo SH, Shin DW, Min JH.   +6 more
europepmc   +1 more source

Coexistence of Acute Demyelinating Polyneuropathy and LRP4-Positive Myasthenia Gravis. [PDF]

Case Rep Neurol Med
Fidancı H, Turhan S, Alaydın HC, Ertürk AY, Öztürk İ.   +4 more
europepmc   +1 more source

BurstDR spinal cord stimulation for chronic inflammatory demyelinating polyneuropathy. [PDF]

Surg Neurol Int
Iovenko D, Jaffee S, Patterson M, Tomycz N.   +3 more
europepmc   +1 more source

Real-world treatment utilization in adults with chronic inflammatory demyelinating polyneuropathy in the United States. [PDF]

Front Neurol
Blein C, Karam C, Arvin-Berod C, Gelinas D, Barrera-Sierra S, Syed HUTA, Ward C, Goyal A, Guptill J.   +8 more
europepmc   +1 more source

Comparative Clinical and Electrophysiological Profiles of Chronic Inflammatory Demyelinating Polyneuropathy in Patients with and without Diabetes Mellitus: An Observational Study. [PDF]

Immunotargets Ther
Al Mamun A, Sumi MSN, Hussain ME, Khan AFMAM, Rassel MA, Kawnayn G, Yusuf MA, Ranjan R, Moureen A, Adhikary D, Alam MB, Mohammad QD, Karim MN.   +12 more
europepmc   +1 more source

Controversies in the diagnosis of chronic inflammatory demyelinating polyneuropathy. [PDF]

Curr Opin Neurol
Doneddu PE, Fasano C, Lozi C, Marenna G, Nobile-Orazio E.   +4 more
europepmc   +1 more source

Case report: Efgartigimod treatment in two pediatric patients with chronic inflammatory demyelinating polyneuropathy. [PDF]

Front Immunol
Ran Y, Wu W, Hou C, Zhu H, Wu W, Chen Z, Ma X, Mo X, Deng H, Gao Y, Li X.   +10 more
europepmc   +1 more source

Comparative efficacy of ripertamab, rituximab, and efgartigimod in chronic inflammatory demyelinating polyneuropathy: an exploratory real-world multicenter cohort study. [PDF]

Front Immunol
Wu Y, Zhou Y, Yin W, Zhao X, Xu L, Su Y, Wang S, Li S, Wang Y, Duan C, Fang Y, Meng Z.   +11 more
europepmc   +1 more source